NAMI
MDGL icon

Nomura Asset Management International’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nomura Asset Management International’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Hold
7,000
– – 0.01% 918
2026
Q1 		$3.66M Sell
7,000
-4,592
-40% -$2.19M 0.01% 840
2025
Q4 		$6.75M Buy
+11,592
New +$5.92M 0.01% 758

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Asset Management International's MDGL Position: Q2 2026 in Review

Nomura Asset Management International held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 7,000 shares worth $3.76M. The position accounts for 0.01% of the portfolio, ranked #918.

Nomura Asset Management International first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.75M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Nomura Asset Management International held 7,000 shares of Madrigal Pharmaceuticals worth $3.76M as of Q2 2026.
  • Nomura Asset Management International left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #918 holding.
  • Nomura Asset Management International first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Madrigal Pharmaceuticals position peaked at $6.75M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.